Bullfrog AI Holdings, Inc. (BFRG)
NASDAQ: BFRG · Real-Time Price · USD
0.7302
-0.0398 (-5.17%)
At close: Jun 3, 2026, 4:00 PM EDT
0.7500
+0.0198 (2.71%)
After-hours: Jun 3, 2026, 7:48 PM EDT
Bullfrog AI Holdings Employees
As of December 31, 2025, Bullfrog AI Holdings had 17 total employees, including 9 full-time and 8 part-time employees. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,863
Profits / Employee
-$357,275
Market Cap
13.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - | 9 | 8 |
| Dec 31, 2024 | 17 | - | - | 9 | 8 |
| Mar 31, 2023 | 7 | 3 | 75.00% | 4 | 3 |
| Dec 31, 2022 | 11 | - | - | 4 | 7 |
| Sep 30, 2022 | 4 | - | - | 2 | 2 |
| Jun 30, 2022 | 4 | - | - | 2 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| CareCloud | 3,650 |
| Health Catalyst | 1,200 |
| VSee Health | 209 |
| DarioHealth | 165 |
| OptimizeRx | 133 |
| Mobile-health Network Solutions | 89 |
| Healthcare Triangle | 41 |
| OneMedNet | 23 |
BFRG News
- 1 day ago - BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform - GlobeNewsWire
- 5 days ago - Bullfrog AI registers to sell 2M shares of common stock for holders - TheFly
- 6 weeks ago - Bullfrog AI regains compliance with Nasdaq - TheFly
- 6 weeks ago - BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement - GlobeNewsWire
- 7 weeks ago - BullFrog AI Announces Participation at AACR Annual Meeting - GlobeNewsWire
- 7 weeks ago - BullFrog AI issues shareholder letter highlighting recent progress, outlook - TheFly
- 7 weeks ago - BullFrog AI issues shareholder letter highlighting recent progress, outlook - TheFly
- 7 weeks ago - BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners - GlobeNewsWire